US Abandons mRNA Vaccine Development Under Trump Administration, World Should Step In
The US withdrawal from mRNA vaccine development is a shocking betrayal of its own scientific and commercial interests. The decision to cancel $500m in funding for 22 projects and signal a "coordinated wind-down" of federal support has sent shockwaves through the global research community.
In the face of a devastating pandemic, the Trump administration's anti-science agenda has led to a catastrophic failure to invest in life-saving technologies. Emergency conditions may have expedited vaccine development, but this is no excuse for abandoning these advances now that they have proven their efficacy against Covid-19.
The science behind mRNA vaccines suggests that loosening traditional constraints could accelerate major scientific breakthroughs. The technology's potential was validated by the rapid development of Covid-19 vaccines and has shown promise in diseases such as flu, HIV, and even cancer.
However, under President Trump's leadership, this progress is being systematically dismantled. The US Department of Health and Human Services' decision to sabotage mRNA research will have devastating consequences for public health and the pharmaceutical industry.
The US has been at the forefront of mRNA development, with companies racing to develop personalized cancer vaccines that could address a huge market opportunity. But under Trump's administration, these efforts are being left untouched due to its radical anti-science agenda.
The world should not stand idly by while this catastrophic failure unfolds. Both public and industry researchers are alarmed, and many are considering relocating their work elsewhere if conditions do not improve. It is now imperative that the UK and EU step in to support mRNA research and development.
The European Commission has already made some positive noises, with a proposed €500m investment and another €100m pledged by France. But more needs to be done to surpass the US as the world's pre-eminent mRNA research and manufacturing centre.
As long as Robert F Kennedy Jr. continues to set policy, American mRNA research will operate in a hostile environment. The rest of the world must now see it through and ensure that these life-saving technologies reach those who need them most.
The US withdrawal from mRNA vaccine development is a shocking betrayal of its own scientific and commercial interests. The decision to cancel $500m in funding for 22 projects and signal a "coordinated wind-down" of federal support has sent shockwaves through the global research community.
In the face of a devastating pandemic, the Trump administration's anti-science agenda has led to a catastrophic failure to invest in life-saving technologies. Emergency conditions may have expedited vaccine development, but this is no excuse for abandoning these advances now that they have proven their efficacy against Covid-19.
The science behind mRNA vaccines suggests that loosening traditional constraints could accelerate major scientific breakthroughs. The technology's potential was validated by the rapid development of Covid-19 vaccines and has shown promise in diseases such as flu, HIV, and even cancer.
However, under President Trump's leadership, this progress is being systematically dismantled. The US Department of Health and Human Services' decision to sabotage mRNA research will have devastating consequences for public health and the pharmaceutical industry.
The US has been at the forefront of mRNA development, with companies racing to develop personalized cancer vaccines that could address a huge market opportunity. But under Trump's administration, these efforts are being left untouched due to its radical anti-science agenda.
The world should not stand idly by while this catastrophic failure unfolds. Both public and industry researchers are alarmed, and many are considering relocating their work elsewhere if conditions do not improve. It is now imperative that the UK and EU step in to support mRNA research and development.
The European Commission has already made some positive noises, with a proposed €500m investment and another €100m pledged by France. But more needs to be done to surpass the US as the world's pre-eminent mRNA research and manufacturing centre.
As long as Robert F Kennedy Jr. continues to set policy, American mRNA research will operate in a hostile environment. The rest of the world must now see it through and ensure that these life-saving technologies reach those who need them most.